12:00 AM
 | 
Feb 27, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Silenor doxepin regulatory update

Somaxon said Health Canada accepted for review an NDS for Silenor doxepin to treat insomnia. Last year, Somaxon granted...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >